Valeant Pharmaceuticals (VRX)
14.09
+0.08 +0.57%
NYSE
Sep 25, 20:00
Delayed 2m
USD
Valeant Pharmaceuticals Key Statistics
Stock Price Performance
| 1 Month Price Returns (Daily) | -0.35% |
| 3 Month Price Returns (Daily) | Upgrade |
| 6 Month Price Returns (Daily) | Upgrade |
| Year to Date Price Returns (Daily) | -2.96% |
| 1 Year Price Returns (Daily) | -49.17% |
| 3 Year Price Returns (Daily) | -88.98% |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| 52-Week High Date | Sep. 26, 2016 |
| 52-Week Low Date | Apr. 24, 2017 |
Dividends and Shares
| Shares Outstanding | 348.52M |
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Cash Dividend Payout Ratio (TTM) | Upgrade |
| Payout Ratio (TTM) | Upgrade |
| Latest Dividend Pay Date | -- |
| Next Ex-Dividend Date | -- |
| Last Split Factor | 2.00 |
| Last Split Date | Oct. 16, 2000 |
Risk Metrics
Estimates
Income Statement
Balance Sheet
Cash Flow Statement
| Cash from Financing (TTM) | -2.963B |
| Cash from Investing (TTM) | 1.865B |
| Cash from Operations (TTM) | 2.304B |
| Capital Expenditures (TTM) | Upgrade |
Common Size Statements
| Net Income (% of Quarterly Revenues) | Upgrade |
| Net Income (% of Annual Revenues) | Upgrade |
Earnings Quality
| Accruals (Quarterly) | Upgrade |
| Beneish M-Score (Annual) | Upgrade |
Profitability
| Gross Profit Margin (Quarterly) | 71.07% |
| Profit Margin (Quarterly) | -1.70% |
| EBITDA Margin (TTM) | Upgrade |
| Operating Margin (TTM) | Upgrade |
Management Effectiveness
Current Valuation
Liquidity and Solvency
Employee Count Metrics
| Total Employees (Annual) | Upgrade |
| Revenue Per Employee (Annual) | Upgrade |
| Net Income Per Employee (Annual) | Upgrade |
